Oral administration of PSK can improve the impaired anti-tumor CD4+ T-cell response in gut-associated lymphoid tissue (GALT) of specific-pathogen-free mice.

Source:http://linkedlifedata.com/resource/pubmed/id/9033641

Int. J. Cancer 1997 Jan 27 70 3 362-72

Download in:

View as

General Info

PMID
9033641